Provided by Tiger Trade Technology Pte. Ltd.

SINOMAB BIO-B

1.080
-0.040-3.57%
Volume:325.20K
Turnover:359.82K
Market Cap:1.50B
PE:-10.80
High:1.115
Open:1.115
Low:1.075
Close:1.120
52wk High:2.200
52wk Low:0.990
Shares:1.39B
HK Float Shares:1.39B
Volume Ratio:0.70
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.100
ROE:-60.37%
ROA:-14.30%
PB:3.54
PE(LYR):-10.80
PS:223.68

Loading ...

SINOMAB BIO-B Grants 18.026 Million Share Options

Stock News
·
Jul 24

Sinomab Bioscience Grants 18,026,040 Share Options at HK$ 1.2 Each

Reuters
·
Jul 24

Sinomab BioScience Reports Stable Share Capital in June; 11.09 Million Options Lapse

Bulletin Express
·
Jul 07

Sinomab Bioscience - Announces Major Deal for Disposal of Suzhou Property and Facility for Rmb280 Mln

THOMSON REUTERS
·
Jul 06

Sinomab Bioscience to Sell Suzhou Property, Facility for RMB 280 Million

Reuters
·
Jul 06

SinoMab BioScience Adds Chief Operating Officer Fang Liang to Board as Executive Director

Bulletin Express
·
Jul 03

SINOMAB BIO-B Appoints Liang Fang as Executive Director

Stock News
·
Jul 03

Sinomab Bioscience Files Board, Board Committee and Management Disclosure List

Reuters
·
Jul 03

Sinomab Bioscience Appoints COO Fang Liang as Executive Director

Reuters
·
Jul 03

Sinomab Bioscience - Appoints Fang Liang as Executive Director Effective 3 July 2026

THOMSON REUTERS
·
Jul 03

SINOMAB BIO-B Appoints Xue Lei as Non-Executive Director

Stock News
·
Jun 12

SinoMab BioScience: AGM Resolutions Secure 100% Support; Lei Xue Named Non-Executive Director

Bulletin Express
·
Jun 12

Hong Kong Stock Movement | SINOMAB BIO-B Surges Over 25% in Late Trading on Robust Pipeline and High BD Potential

Stock News
·
Jun 11

Sinomab Bio-B Maintains 1.39 Billion Issued Shares and Public Float Compliance in May 2026 Return

Bulletin Express
·
Jun 04

SinoMab Presents Preclinical Study Data of Vitiligo, Alopecia Drug at Dermatology Conference

MT Newswires Live
·
May 14

Revised Title

Stock News
·
May 14

Sinomab Bioscience posts unchanged share capital and maintains public float in April 2026 monthly return

Bulletin Express
·
May 06

SinoMab BioScience releases 2025 ESG report

Reuters
·
Apr 27

SinoMab BioScience unveils 2026 AGM agenda: board changes, 10% share buy-back mandate and 20% issuance limit

Bulletin Express
·
Apr 27

SinoMab BioScience announces annual general meeting

Reuters
·
Apr 27